High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$4.8M
$4,824,507
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
BEAM
S
Beam Therapeutics Inc.
Ciaramella Giuseppe
• President
10b5-1 SellΔOwn -15.5%
2026-02-24
$1,120,042Large
|
||||||
| BEAM |
Beam Therapeutics Inc.
|
President
10b5-1 SellΔOwn -15.5%
|
2026-02-24 | $1,120,042Large | S | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
President
Other
|
2026-02-24 | $595,000 | M | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
Other
|
2026-01-30 | $16,750 | M | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-01-30 | $84,274 | S | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-01-30 | $624,672 | S | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
Other
|
2026-01-29 | $3,795 | M | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-01-29 | $257,781 | S | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2026-01-29 | $476,801 | S | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
Other
|
2026-01-29 | $12,955 | M | Form 4 |
|
BEAM
S
Beam Therapeutics Inc.
Bellon Christine
• Officer • Chief Legal Officer
10b5-1 Sell
2026-01-22
$46,614
|
||||||
| BEAM |
Beam Therapeutics Inc.
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2026-01-22 | $46,614 | S | Form 4 |
|
BEAM
S
Beam Therapeutics Inc.
Cavanagh Bethany J
• Officer • SVP, Finance and Treasurer
10b5-1 SellΔOwn -15.1%
2026-01-22
$216,933
|
||||||
| BEAM |
Beam Therapeutics Inc.
|
Officer • SVP, Finance and Treasurer
10b5-1 SellΔOwn -15.1%
|
2026-01-22 | $216,933 | S | Form 4 |
|
BEAM
S
Beam Therapeutics Inc.
Cavanagh Bethany J
• Officer • SVP, Finance and Treasurer
10b5-1 Sell
2026-01-20
$91,384
|
||||||
| BEAM |
Beam Therapeutics Inc.
|
Officer • SVP, Finance and Treasurer
10b5-1 Sell
|
2026-01-20 | $91,384 | S | Form 4 |
|
BEAM
S
Beam Therapeutics Inc.
Bellon Christine
• Officer • Chief Legal Officer
10b5-1 Sell
2026-01-15
$70,976
|
||||||
| BEAM |
Beam Therapeutics Inc.
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2026-01-15 | $70,976 | S | Form 4 |
|
BEAM
S
Beam Therapeutics Inc.
Bellon Christine
• Officer • Chief Legal Officer
10b5-1 Sell
2026-01-15
$19,788
|
||||||
| BEAM |
Beam Therapeutics Inc.
|
Officer • Chief Legal Officer
10b5-1 Sell
|
2026-01-15 | $19,788 | S | Form 4 |
|
BEAM
S
Beam Therapeutics Inc.
Bellon Christine
• Officer • Chief Legal Officer
10b5-1 SellΔOwn -14.1%
2026-01-15
$554,068
|
||||||
| BEAM |
Beam Therapeutics Inc.
|
Officer • Chief Legal Officer
10b5-1 SellΔOwn -14.1%
|
2026-01-15 | $554,068 | S | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
10% Owner
Discretionary SellΔOwn -97.0%
|
2025-10-27 | $12,246 | S | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2025-10-02 | $615,668 | S | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
Other
|
2025-10-02 | $16,750 | M | Form 4 |
|
BEAM
S
Beam Therapeutics Inc.
Cavanagh Bethany J
• Officer • SVP, Finance and Treasurer
Sell to Cover
2025-10-01
$11,456
|
||||||
| BEAM |
Beam Therapeutics Inc.
|
Officer • SVP, Finance and Treasurer
Sell to Cover
|
2025-10-01 | $11,456 | S | Form 4 |
|
BEAM
S
Beam Therapeutics Inc.
Bellon Christine
• Officer • Chief Legal Officer
Sell to Cover
2025-10-01
$9,150
|
||||||
| BEAM |
Beam Therapeutics Inc.
|
Officer • Chief Legal Officer
Sell to Cover
|
2025-10-01 | $9,150 | S | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
10b5-1 Sell
|
2025-10-01 | $612,655 | S | Form 4 |
| BEAM |
Beam Therapeutics Inc.
|
CEO
Other
|
2025-10-01 | $16,750 | M | Form 4 |